Medicare's new payment model is a game-changer, and yet, it seems like the tech world is largely oblivious to its significance. This model, designed to embrace AI-driven medical care, is set to revolutionize healthcare, but the question remains: Who will take the lead in this transformation? Neil Batlivala, a visionary entrepreneur, has been quietly building a healthcare company that is now at the forefront of this movement. His company, Pair Team, has been accepted into the ACCESS program, a Medicare initiative that aims to test the potential of AI-driven care on a federal scale.
What makes this particularly fascinating is the payment structure. Traditional Medicare reimburses based on time spent with a clinician, but ACCESS introduces a game-changing payment model. It rewards health outcomes rather than required activities, providing predictable payments for managing qualifying conditions. This means that AI agents can now be reimbursed for monitoring patients between visits, coordinating referrals, and ensuring medication adherence. It's a payment model transformation that wasn't possible before.
One of the key strengths of Pair Team is its focus on addressing the full context of a patient's life. The company launched in 2019 with a specific patient population in mind: those managing chronic conditions who also struggle with unstable housing, food insecurity, or lack of transportation. By employing roughly 850 clinical professionals and running the largest community health workforce in California, Pair Team has generated significant revenue and demonstrated peer-reviewed evidence of its success. A study evaluating their community-integrated model showed strong patient engagement and significant reductions in avoidable emergency and inpatient utilization.
However, the real innovation came about nine months ago when Pair Team deployed a voice AI agent called Flora as its primary patient-facing interface. Flora handles intake, coordinates referrals, and keeps patients engaged between clinical visits, providing companionship and support. This shift in approach has been transformative, as Flora offers a level of care and attention that was previously unattainable with human teams alone.
The architects of ACCESS, Abe Sutton and Jacob Shiff, bring a unique perspective to the program. Sutton, a former venture capitalist, and Shiff, a former healthcare founder, have designed a program that encourages competition and direct-to-consumer enrollment. However, there are risks associated with this initiative. Participants are handling sensitive patient data, and the federal infrastructure has a history of breaches. Additionally, financial risks exist, as the track record of CMS innovation programs is mixed, and reimbursement rates may not be sufficient for all participants.
In my opinion, the reimbursement concern is a feature, not a bug. Building a model that truly incentivizes AI usage requires low reimbursement rates, and Pair Team's lean, AI-first operation is well-positioned to succeed. With partnerships in place and a focus on scaling, Pair Team is poised to reach a million patients within three years. Healthcare investors are taking notice, and digital health funding is on the rise, with AI companies capturing the bulk of it.
What makes this story even more intriguing is the contrast between the potential of AI-driven care and the lack of awareness in the tech world. While healthcare investors are eagerly watching this space, the general public and many tech companies remain oblivious to the significance of Medicare's new payment model. It raises a deeper question: Who will be the pioneers in this AI-driven healthcare revolution? In my view, companies like Pair Team are leading the way, and their success will shape the future of healthcare.
